Blog
RSS FeedPosted by Michael Wonder on 02 Nov 2020
NICE talking to you: trends in early HTA engagement
29 October 2020 - In 2009, NICE was one of the first health technology assessment agencies to offer the opportunity ...
Posted by Michael Wonder on 19 Aug 2020
Keeping pace with pharmaceutical innovation: the importance of the NICE methods review
19 August 2020 - The NICE plays a vitally important role in ensuring patients get timely access to new medicines ...
Posted by Michael Wonder on 17 Aug 2020
NICE publishes guidance on Astellas' Xospata
17 August 2020 - The National Institute for Health and Care Excellence has now published final guidance backing NHS use ...
Posted by Michael Wonder on 10 Oct 2019
Elmiron bags draft NICE approval
10 October 2019 - NICE has published a draft final appraisal regarding Elmiron (pentosan polysulfate sodium) for bladder pain syndrome. ...
Posted by Michael Wonder on 02 Oct 2019
Advancing patient engagement
2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...
Posted by Michael Wonder on 18 Jun 2019
NICE to co-host 2021 HTAi Annual Meeting in Manchester
18 June 2019 - Health Technology Assessment International (HTAi) has announced that NICE has been chosen as co-hosts of their 2021 ...
Posted by Michael Wonder on 02 Apr 2019
NICE nod for breast cancer delay drug
2 April 2019 - NICE has recommended Eli Lilly’s Verzenio (abemaciclib) when given with Faslodex (fulvestrant), to be available for ...
Posted by Michael Wonder on 22 Sep 2018
The FDA announces Patient Engagement Advisory Committee meeting on utilising real world data from patient-driven platforms that connect and empower patients
21 September 2018 - On 15 November 2018, the FDA’s Patient Engagement Advisory Committee will hold its second public meeting ...
Posted by Michael Wonder on 14 Jun 2018
Building synergy between regulatory and HTA agencies beyond processes and procedures—can we effectively align the evidentiary requirements? A survey of stakeholder perceptions
13 June 2018 - The pathway for bringing a new medicine to the market is dependent on two sequential processes: achieving ...
Posted by Michael Wonder on 16 May 2018
Patient empowerment in Europe: is no further research needed?
15 May 2018 - In economic theory, health care can be considered a clear example of ‘market failure’ caused by ...
Posted by Michael Wonder on 18 Apr 2018
Deputy Ministers call out patient engagement as key to transforming health care
17 April 2018 - The 2018 CADTH Symposium officially kicked off in Halifax with a panel of senior healthy policy ...
Posted by Michael Wonder on 15 Mar 2018
NICE Medtech Early Technical Assessment tool to form part of government grant application process for health care product developers
15 March 2018 - The Medtech Early Technical Assessment (META) tool has been selected , as an option, to form part ...
Posted by Michael Wonder on 08 Mar 2018
Patient and public involvement in early awareness and alert activities: an example from the United Kingdom
6 March 2018 - The aim of this study is to report on the experiences, benefits, and challenges of patient and ...
Posted by Michael Wonder on 05 Mar 2018
NHS prescription charges are rising – here’s how to keep them down
3 March 2016 - Here’s what you need to know about the increase – and how to get cheaper everyday medicines. ...
Posted by Michael Wonder on 30 Jan 2018
The impact of parallel regulatory-HTA scientific advice on clinical development. Assessing the uptake of regulatory and HTA recommendations.
30 January 2018 - The “Parallel regulatory-HTA scientific advice” procedure allows manufacturers to receive simultaneous feedback from both EU regulators and ...